IE
BNTC icon

Israel Englander’s Benitec Biopharma BNTC Stock Holding History

Israel Englander’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
921,299
+269,235
+41% +$3.19M ﹤0.01% 2076
2026
Q1 		$6.94M Buy
652,064
+38,904
+6% +$450K ﹤0.01% 2573
2025
Q4 		$8.26M Buy
+613,160
New +$8.48M ﹤0.01% 2469
2025
Q2 		– Sell
-32,046
Closed -$417K – 5875
2025
Q1 		$417K Buy
+32,046
New +$388K ﹤0.01% 4915
2022
Q4 		– Sell
-3,070
Closed -$19K – 6582
2022
Q3 		$19K Buy
3,070
+1,592
+108% +$20.2K ﹤0.01% 6474
2022
Q2 		$29K Buy
+1,478
New +$34.4K ﹤0.01% 6380

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Israel Englander's BNTC Position: Q2 2026 in Review

Israel Englander increased its Benitec Biopharma (BNTC) stake by 41% in Q2 2026, buying an estimated $3.19M and bringing the position to 921,299 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Israel Englander first reported a position in BNTC in Q2 2022 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Israel Englander held 921,299 shares of Benitec Biopharma worth $12.3M as of Q2 2026.
  • Israel Englander bought 269,235 Benitec Biopharma shares in Q2 2026, an estimated $3.19M.
  • Benitec Biopharma made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2076 holding.
  • Israel Englander first reported a position in Benitec Biopharma in Q2 2022 and has held it in 6 quarters since.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.